|
RTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.828000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.359500E-02 |
| Normal-vs-Stage2 |
4.048400E-01 |
| Normal-vs-Stage3 |
4.606000E-01 |
| Normal-vs-Stage4 |
2.720600E-01 |
| Stage1-vs-Stage2 |
7.454000E-01 |
| Stage1-vs-Stage3 |
6.053600E-01 |
| Stage1-vs-Stage4 |
7.884200E-01 |
| Stage2-vs-Stage3 |
9.166800E-01 |
| Stage2-vs-Stage4 |
6.622400E-01 |
| Stage3-vs-Stage4 |
6.115600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.341700E-02 |
| Normal-vs-AfricanAmerican |
5.899800E-01 |
| Normal-vs-Asian |
2.711200E-01 |
| Caucasian-vs-AfricanAmerican |
1.544820E-01 |
| Caucasian-vs-Asian |
9.940600E-01 |
| AfricanAmerican-vs-Asian |
6.321600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.099300E-03 |
| Normal-vs-Female |
4.174600E-01 |
| Male-vs-Female |
2.244300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.688240E-01 |
| Normal-vs-Extreme_Weight |
4.755500E-03 |
| Normal-vs-Obese |
2.242200E-01 |
| Normal-vs-Extreme_Obese |
9.297700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.220400E-01 |
| Normal_Weight-vs-Obese |
6.906800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.073600E-01 |
| Extreme_Weight-vs-Obese |
1.535400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.302200E-01 |
| Obese-vs-Extreme_Obese |
5.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.121200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.630000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.504570E-03 |
| Normal-vs-Age(81-100Yrs) |
5.698400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.537400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.465370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.453600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.197200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.432000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.180800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.170400E-01 |
| Normal-VS-Type2 PRCC |
2.357400E-03 |
| Normal-VS-KIRP CIMP |
5.115800E-01 |
| Normal-VS-Unclassified PRCC |
2.545800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.529900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.892800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.236000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.424200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.566400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.001400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.186500E-04 |
| Normal-vs-N1 |
6.017400E-01 |
| Normal-vs-N2 |
4.968600E-01 |
| N0-vs-N1 |
9.170100E-02 |
| N0-vs-N2 |
7.616800E-01 |
| N1-vs-N2 |
6.071200E-01 |
|
|
